|
|
|
| () | |
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Page 1 of 1
-
Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
on May 09, 2008 by Don Dion
-
Russell 1,000 Stocks Up and Down the Most Since the 3/10 Bottom
on May 05, 2008 by Bespoke Investment Group
-
Today's 52-Week High List: Energy Dominates
on Apr 16, 2008 by Bespoke Investment Group
-
General Electric's Healthcare Disappointment
on Apr 14, 2008 by Michael Steinberg
-
Last Week's Winners and Losers
on Apr 14, 2008 by Bespoke Investment Group
-
Millennium Has Nothing to Fear from a Takeda Takeover
on Apr 13, 2008 by Derek Lowe
-
Wall Street Breakfast: Must-Know News
on Apr 10, 2008 by SA Editor Eli Hoffmann
-
Earnings Preview: Millennium Pharmaceuticals
on Feb 07, 2008 by theflyonthewall.com
-
Strongest Upward Revisions Heading Into Earnings
on Jan 09, 2008 by Bespoke Investment Group
-
Russell 1,000's Best, Worst Performers Since the 10/9 Top
on Nov 26, 2007 by Bespoke Investment Group
-
Who are the Russell 1,000's Most Overbought and Oversold Stocks?
on Nov 06, 2007 by Bespoke Investment Group
-
PBE: Large Biotech Meets Small Biotech
on Oct 04, 2007 by Don Dion
-
Millennium’s Velcade a Phase III Trial Success
on Sep 18, 2007 by SA Editor Roy Mehta
-
Thursday's Options Report: Apple, Ford, Kraft, Baidu, Emulex, Millennium
on Jul 26, 2007 by Andrew Wilkinson
-
Cancer Stocks: The Bleeding Slows
on Jul 02, 2007 by Alan Brochstein
-
Millenium Pharmaceuticals A Sell On Strong Competition, Slowed Growth
on Jun 27, 2007 by Zacks.com
-
Cancer Stocks Hammered Once Again
on Jun 26, 2007 by Alan Brochstein
-
Cancer Stocks Slide Again
on Jun 18, 2007 by Alan Brochstein
-
Cancer Stocks Plunge Following ASCO Meeting
on Jun 11, 2007 by Alan Brochstein
-
Cancer Stocks Soar With Annual ASCO Meeting
on Jun 04, 2007 by Alan Brochstein
-
Cancer Stocks on the Go: Winners and Losers
on May 29, 2007 by Alan Brochstein
-
Biotechs Make Appearances in Best and Worst Lists of WSJ Review
on Feb 26, 2007 by Centient Biotech Investor
-
Report From JPMorgan's HealthCare Conference: The Spinal Business Is Hot
on Jan 10, 2007 by Centient Biotech Investor
-
Millenium Ends Its Bid For AnorMED, Leaving Genzyme On Top
on Oct 17, 2006 by H.S. Ayoub
-
Bidding War Continues for AnorMED's Stem Cell Drug
on Oct 05, 2006 by H.S. Ayoub
-
Millenium Beats Genzyme, Gets AnorMED's Stem Cell Drug
on Sep 27, 2006 by H.S. Ayoub
-
Stocks Covered by The Biotech Stock Blog
on Oct 11, 2005
Get Free Stock Alerts by Email!
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »